WHO Drug Information Vol. 25, No. 2, 2011

Proposed INN: List 105 WHO Drug Information Vol. 25, No. 2, 2011C 31 H 36 F 6 N 6 O 2 1186486-62-3H 3 CCH 3F 3 CCF 3NHH HNCO 2 HN NN NCH 3exeporfinii chloridumexeporfinium chloridechlorure d'exéporfiniumcloruro de exeporfinio3,3'-(21H,23H-porphyrin-5,15-diylbis{[(4,1-phenylene)oxy]-N,N,Ntrimethylpropan-1-aminium})dichlorideantibacterialdichlorure de 3,3'-[21H,23H-porphyrin-5,15-diylbis(4,1-phénylèneoxy)]bis[N,N,N-triméthylpropan-1-aminium]antibactériendicloruro de 3,3'-(21H,23H-porfirin-5,15-diilbis{[(4,1-fenileno)oxi]-N,N,N-trimetilpropan-1-aminium})antibacterianoC 44 H 50 Cl 2 N 6 O 2 718638-68-7OClCHH 3 C 3N CH 3NHNNHNH 3 C NH 3 CClCH3OfaciniclinumfaciniclinefaciniclinefaciniclinaN-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-1H-indazole-3-carboxamidenicotinic acetylcholine receptor partial agonistN-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-1H-indazole-3-carboxamideagoniste partiel du récepteur nicotinique à l'acétylcholineN-[(3S)-1-azabiciclo[2.2.2]octan-3-il]-1H-indazol-3-carboxamidaagonista parcial del receptor nicotínico de la acetilcolinaC 15 H 18 N 4 O 677306-35-3NOHNHNNH170